Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Equity (Unaudited)

v3.23.3
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2021 7,053,146            
Issuance of common stock related to restricted stock award (in shares) 10,000            
Issuance of common stock related to restricted stock award $ 1 $ 34,799 $ 0 $ 0     $ 34,800
Issuance of common stock related to April offering (in shares) 2,229,950            
Issuance of common stock related to April offering $ 223 7,004,815 0 0     7,005,038
Balance (in shares) at Mar. 31, 2022 9,293,096            
Balance at Dec. 31, 2021 $ 705 39,513,093 (21,986,215) 3,236     17,530,819
Comprehensive loss 0 0 0 (15,330)     (15,330)
Net loss 0 0 (850,083) 0     (850,083)
Balance at Mar. 31, 2022 $ 929 46,552,707 (22,836,298) (12,094)     23,705,244
Balance (in shares) at Dec. 31, 2021 7,053,146            
Net loss             (8,219,220)
Balance (in shares) at Sep. 30, 2022 9,649,096            
Balance at Dec. 31, 2021 $ 705 39,513,093 (21,986,215) 3,236     17,530,819
Net loss             (8,219,220)
Balance at Sep. 30, 2022 $ 965 48,481,636 (30,205,435) (84,517)     18,192,649
Balance (in shares) at Mar. 31, 2022 9,293,096            
Issuance of common stock related to restricted stock award $ 0 654,246 0 0     654,246
Balance (in shares) at Jun. 30, 2022 9,293,096            
Balance at Mar. 31, 2022 $ 929 46,552,707 (22,836,298) (12,094)     23,705,244
Comprehensive loss 0 0 0 (4,788)     (4,788)
Net loss 0 0 (1,655,861) 0     (1,655,861)
Balance at Jun. 30, 2022 $ 929 47,206,953 (24,492,159) (16,882)     22,698,841
Issuance of common stock related to restricted stock award (in shares) 356,000            
Issuance of common stock related to restricted stock award $ 36 654,484 0 0     654,520
Net loss             (5,713,276)
Stock-based compensation in connection with options granted $ 0 620,199 0 0     620,199
Balance (in shares) at Sep. 30, 2022 9,649,096            
Comprehensive loss $ 0 0 0 (67,635)     (67,635)
Net loss 0 0 (5,713,276) 0     (5,713,276)
Balance at Sep. 30, 2022 $ 965 48,481,636 (30,205,435) (84,517)     18,192,649
Balance (in shares) at Dec. 31, 2022 14,402,025            
Balance at Dec. 31, 2022 $ 1,440 56,963,200 (31,146,804) (40,717) $ 25,777,119 $ 0 25,777,119
Issuance of common stock related to restricted stock award (in shares) 39,000            
Issuance of common stock related to restricted stock award $ 4 60,536 0 0 60,540 0  
Comprehensive loss 0 0 0 (22,985) (22,985) 0  
Net loss $ 0 0 (1,187,230) 0 (1,187,230) 0  
Balance (in shares) at Mar. 31, 2023 14,441,025            
Balance at Mar. 31, 2023 $ 1,444 57,023,736 (32,334,034) (63,702) 24,627,444 0  
Balance at Dec. 31, 2022             25,777,119
Balance (in shares) at Dec. 31, 2022 14,402,025            
Balance at Dec. 31, 2022 $ 1,440 56,963,200 (31,146,804) (40,717) 25,777,119 0 25,777,119
Net loss             (2,891,557)
Balance (in shares) at Sep. 30, 2023 18,724,596            
Balance at Sep. 30, 2023 $ 1,872 66,469,956 (33,227,122) (56,869) 33,187,837 16,348,086 49,535,923
Balance at Dec. 31, 2022             25,777,119
Net loss             (2,080,318)
Balance at Sep. 30, 2023             33,187,837
Balance (in shares) at Mar. 31, 2023 14,441,025            
Balance at Mar. 31, 2023 $ 1,444 57,023,736 (32,334,034) (63,702) 24,627,444 0  
Issuance of common stock related to restricted stock award (in shares) 725,000            
Issuance of common stock related to restricted stock award $ 73 1,183,061 0 0 1,183,134 0  
Comprehensive loss 0 0 0 (11,968) (11,968) 0  
Net loss $ 0 0 (4,340,741) 0 (4,340,741) 0  
Issuance of common stock related to April offering (in shares) 3,428,571            
Issuance of common stock related to April offering $ 343 5,999,657 0 0 6,000,000 0  
Issuance of common stock related to exercise of warrants (in shares) 105,000            
Issuance of common stock related to exercise of warrants $ 10 183,740 0 0 183,750 0  
Stock-based compensation in connection with options granted $ 0 780,867 0 0 780,867 0  
Balance (in shares) at Jun. 30, 2023 18,699,596            
Balance at Jun. 30, 2023 $ 1,870 65,171,061 (36,674,775) (75,670) 28,422,486 0  
Issuance of common stock related to restricted stock award (in shares) 25,000            
Issuance of common stock related to restricted stock award $ 2 836,716 0 0 836,718 150,003  
Comprehensive loss 0 0 0 18,801 18,801 0  
Net loss 0 0 3,447,653 0 3,447,653 (811,239) 2,636,414
Stock-based compensation in connection with options granted 0 496,916 0 0 496,916    
Acquisition of subsidiary and noncontrolling interests $ 0 (34,737)   0 (34,737) 15,957,487  
Acquisition of subsidiary and noncontrolling interests     0        
Stock-based compensation in connection with options granted           1,051,835  
Balance (in shares) at Sep. 30, 2023 18,724,596            
Balance at Sep. 30, 2023 $ 1,872 $ 66,469,956 $ (33,227,122) $ (56,869) $ 33,187,837 $ 16,348,086 49,535,923
Net loss             3,447,653
Balance at Sep. 30, 2023             $ 33,187,837